SetmelanotideWeight LossSafety Rating 8/10
Primary research areaRare genetic obesity (POMC/PCSK1/LEPR deficiency)
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range1-3 mg daily
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Imcivree)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Setmelanotide
Mechanism of action
Melanocortin-4 receptor agonist; restores MC4R signaling
Safety profile
Hyperpigmentation, nausea, spontaneous erection · Approved for genetic obesity; skin hyperpigmentation; injection site reactions; penile erections
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Setmelanotide below your target.
Related pages